Your browser doesn't support javascript.
loading
Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women.
Renz, Susanne; Chinnery, Fay; Stuart, Beth; Day, Laura; Muller, Ingrid; Soulsby, Irene; Nuttall, Jacqui; Thomas, Karen; Thomas, Kim Suzanne; Sach, Tracey; Stanton, Louise; Ridd, Matthew J; Francis, Nick; Little, Paul; Eminton, Zina; Griffiths, Gareth; Layton, Alison M; Santer, Miriam.
Afiliación
  • Renz S; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Chinnery F; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Stuart B; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Day L; Primary Care Research Centre, Faculty of Medicine, School of Primary Care, Population Sciences and Medical Education, University of Southampton, Southampton, UK.
  • Muller I; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Soulsby I; Primary Care Research Centre, Faculty of Medicine, School of Primary Care, Population Sciences and Medical Education, University of Southampton, Southampton, UK.
  • Nuttall J; PPI representative, Wickham, UK.
  • Thomas K; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Thomas KS; Acne Support, PPI representative, Cambridgeshire, UK.
  • Sach T; School of Medicine, Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK.
  • Stanton L; Health Economics Group, Norwich Medical School, University of East Anglia, Norwich, UK.
  • Ridd MJ; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Francis N; Population Health Sciences, University of Bristol Faculty of Health Sciences, Bristol, UK.
  • Little P; Primary Care Research Centre, Faculty of Medicine, School of Primary Care, Population Sciences and Medical Education, University of Southampton, Southampton, UK.
  • Eminton Z; Primary Care Research Centre, Faculty of Medicine, School of Primary Care, Population Sciences and Medical Education, University of Southampton, Southampton, UK.
  • Griffiths G; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Layton AM; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Santer M; Hull York Medical School, University of York, York, UK.
BMJ Open ; 11(8): e053876, 2021 08 26.
Article en En | MEDLINE | ID: mdl-34446504
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Espironolactona / Acné Vulgar Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Female / Humans Idioma: En Revista: BMJ Open Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Espironolactona / Acné Vulgar Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Female / Humans Idioma: En Revista: BMJ Open Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido